Parametric Portfolio Associates’s Albany Molecular Research Inc AMRI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-36,483
| Closed | -$792K | – | 4099 |
|
|
2017
Q2 | $792K | Buy |
36,483
+7,143
| +24% | +$130K | ﹤0.01% | 3106 |
|
|
2017
Q1 | $412K | Sell |
29,340
-21,855
| -43% | -$358K | ﹤0.01% | 3293 |
|
|
2016
Q4 | $960K | Buy |
51,195
+28,132
| +122% | +$478K | ﹤0.01% | 2854 |
|
|
2016
Q3 | $381K | Buy |
23,063
+3,980
| +21% | +$59K | ﹤0.01% | 3305 |
|
|
2016
Q2 | $256K | Sell |
19,083
-689
| -3% | -$10.1K | ﹤0.01% | 3518 |
|
|
2016
Q1 | $302K | Buy |
19,772
+2,220
| +13% | +$34.8K | ﹤0.01% | 3603 |
|
|
2015
Q4 | $348K | Sell |
17,552
-28,385
| -62% | -$539K | ﹤0.01% | 3480 |
|
|
2015
Q3 | $800K | Sell |
45,937
-1,733
| -4% | -$35.3K | ﹤0.01% | 2468 |
|
|
2015
Q2 | $964K | Sell |
47,670
-1,636
| -3% | -$31.6K | ﹤0.01% | 2836 |
|
|
2015
Q1 | $868K | Sell |
49,306
-24,223
| -33% | -$413K | ﹤0.01% | 2891 |
|
|
2014
Q4 | $1.2M | Sell |
73,529
-54,285
| -42% | -$996K | ﹤0.01% | 2629 |
|
|
2014
Q3 | $2.82M | Sell |
127,814
-55,330
| -30% | -$1.13M | 0.01% | 1722 |
|
|
2014
Q2 | $3.69M | Sell |
183,144
-10,784
| -6% | -$183K | 0.01% | 1473 |
|
|
2014
Q1 | $3.6M | Buy |
193,928
+45,171
| +30% | +$622K | 0.01% | 1433 |
|
|
2013
Q4 | $1.5M | Buy |
148,757
+41,585
| +39% | +$503K | ﹤0.01% | 2304 |
|
|
2013
Q3 | $1.38M | Buy |
107,172
+60,274
| +129% | +$741K | ﹤0.01% | 2281 |
|
|
2013
Q2 | $557K | Buy |
+46,898
| New | +$508K | ﹤0.01% | 2883 |
|
Other funds holding AMRI
Parametric Portfolio Associates's AMRI Position: Q3 2017 in Review
Parametric Portfolio Associates sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 36,483 shares — an estimated $792K sold.
Parametric Portfolio Associates first reported a position in AMRI in Q2 2013 and held it in 17 quarters. The position peaked at $3.69M in Q2 2014. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.
- Parametric Portfolio Associates reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
- Parametric Portfolio Associates sold 36,483 Albany Molecular Research Inc shares in Q3 2017, an estimated $792K.
- Parametric Portfolio Associates first reported a position in Albany Molecular Research Inc in Q2 2013 and held it in 17 quarters.
- Parametric Portfolio Associates's Albany Molecular Research Inc position peaked at $3.69M in Q2 2014.
- 2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.
Based on Parametric Portfolio Associates's 13F filing for Q3 2017, filed 14 Nov 2017.